Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Erdmann

Showing results (331-340 of 547) with videos related to

Pageof 55
Sort By:
Circulation|December 1, 1992
Force-frequency relation in human heart failureR H Schwinger, M Böhm, A Koch, et al.
American Heart Journal|December 1, 1990
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activityM Böhm, C Mittmann, R H Schwinger, et al.
American Heart Journal|April 1, 1995
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failureD J Beuckelmann, M Näbauer, C Krüger, et al.
Cell Calcium|December 1, 1994
Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failureC Krüger, E Erdmann, M Näbauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Lack of correlation of digitalis poisoning symptoms and serum digoxin level - clinical and experimental findings]E Erdmann, T von Arnim, W Krawietz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1980
Is the determination of serum digoxin concentration useful for the diagnosis of digitalis toxicity?T von Arnim, W Krawietz, W Vogt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2011
Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive studyR Pfister, R Cairns, E Erdmann, et al.
Basic Research in Cardiology|September 1, 1995
EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardiumR Uhlmann, R H Schwinger, I Lues, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Therapy with glitazones--a risk for cardiovascular disease?]D Rottlaender, G Michels, E Erdmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1990
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardiumM Ungerer, M Böhm, R H Schwinger, et al.
Pageof 55

Showing results (331-340 of 547) with videos related to

Sort By:
Pageof 55
Circulation|December 1, 1992
Force-frequency relation in human heart failureR H Schwinger, M Böhm, A Koch, et al.
American Heart Journal|December 1, 1990
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activityM Böhm, C Mittmann, R H Schwinger, et al.
American Heart Journal|April 1, 1995
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failureD J Beuckelmann, M Näbauer, C Krüger, et al.
Cell Calcium|December 1, 1994
Intracellular calcium handling in isolated ventricular myocytes from cardiomyopathic hamsters (strain BIO 14.6) with congestive heart failureC Krüger, E Erdmann, M Näbauer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|April 17, 1977
[Lack of correlation of digitalis poisoning symptoms and serum digoxin level - clinical and experimental findings]E Erdmann, T von Arnim, W Krawietz, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1980
Is the determination of serum digoxin concentration useful for the diagnosis of digitalis toxicity?T von Arnim, W Krawietz, W Vogt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 11, 2011
Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive studyR Pfister, R Cairns, E Erdmann, et al.
Basic Research in Cardiology|September 1, 1995
EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardiumR Uhlmann, R H Schwinger, I Lues, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Therapy with glitazones--a risk for cardiovascular disease?]D Rottlaender, G Michels, E Erdmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1990
Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardiumM Ungerer, M Böhm, R H Schwinger, et al.
Pageof 55